The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1166
September 29, 2003
View Complete Issue         Table of Contents 2019 
Vardenafil (Levitra) for Erectile Dysfunction
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Vardenafil (Levitra) for Erectile Dysfunction
September 29, 2003 (Issue: 1166)
Vardenafil (Levitra -Bayer) is the second oral drug approved by the FDA for treatment of erectile dysfunction. Sildenafil (Viagra - Medical Letter 1998; 40:51), the first oral drug, has been available for 5 years. Pharmacokinetics, effectiveness,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Vardenafil (Levitra) for Erectile Dysfunction
Article code: 1166a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.